Syphilis is an endemic public health problem that affects infants, children and adults. Syphilis diagnoses continue to increase nationwide and in Louisiana, which has historically had high rates of syphilis infection. To combat the resurgence of syphilis and improve the health of our patients and community, healthcare providers need to understand the symptoms, impact, diagnosis and treatment of syphilis.
At the conclusion of this presentation, the learner will be able to:
- recognize the signs and symptoms of syphilis in infants and adults
- determine the appropriate testing strategy for diagnosis of syphilis
- initiate prompt treatment of syphilis based on the stage of disease
- report syphilis diagnoses to appropriate public health agencies for contact tracing.
Thursday, October 26, 2022, @ Noon
John Vanchiere, MD
This training is eligible for CME credit.
Registration Link: https://centene.zoom.us/webinar/register/WN_E6Eoct1jQgioXf-6X-jcJw
The Louisiana AAP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Louisiana AAP is accredited by the Texas Medical Association to provide continuing medical education for physicians.
John Vanchiere has disclosed that he administers clinical trial contracts with Pfizer, Merck, Enanta, and Biocryst and consults for Syneos and Seqirus. Louisiana AAP planning committee member, Joseph Bocchini, Jr., MD, has disclosed that he has received research grant funds from Regeneron and Novavax and sits on the Advisory Board for Pfizer and Dynavax. All remaining faculty, Louisiana AAP Education Committee members and staff have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated.